Your session is about to expire
← Back to Search
Paclitaxel for Non-Small Cell Lung Cancer (TOP1705 Trial)
TOP1705 Trial Summary
This trial will test the safety and effectiveness of two immunotherapy drugs, nivolumab and ipilimumab, when given with the chemotherapy drug paclitaxel to people with lung cancer that has not been treated before.
- Non-Small Cell Lung Cancer
TOP1705 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTOP1705 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TOP1705 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does Nivolumab have the FDA's official stamp of approval?
"Nivolumab's safety is estimated to be a 2. This is due to it being in Phase 2 trials, so while there is evidence that it won't create too many adverse effects, efficacy has yet to be studied."
Nivolumab is most commonly associated with which type of illness?
"Nivolumab can be used as an immunotherapy treatment for patients with unresectable melanoma, squamous cell carcinoma, and those at a high risk of cancer recurrence."
What is the existing research on Nivolumab's efficacy?
"As of now, there are 1623 ongoing clinical trials researching Nivolumab. Out of these studies, 309 are in Phase 3. Most studies for Nivolumab are based in Shanghai; however, there are a total of 83232 locations conducting research on this medication."
How many people are enrolling in this clinical trial?
"This particular study is no longer recruiting patients. It was initially posted on October 2nd, 2018 and was edited for the last time on April 22nd, 2022. For those still searching for clinical trials to participate in, there are currently 2002 trials for lung cancer and 1623 studies involving Nivolumab that are actively enrolling patients."
Are people still being signed up for this experiment?
"Unfortunately, this particular study is not recruiting candidates at the moment. The listing on clinicaltrials.gov indicates that it was originally posted on October 2nd 2018 and last updated on April 22nd 2022. With that said, there are 3,625 other trials actively looking for patients right now."
Share this study with friends
Copy Link
Messenger